A few studies on squamous cell carcinoma considered this protein as a tumor suppressor[37], whereas MYH9 overexpression in various malignancies such as pancreatic cancer[38] esophageal squamous cell carcinoma[39], lung carcinoma[40], and acute myeloid leukemia[41] was associated with aggressiveness, poor prognosis, and reduction in therapeutic response. Here, MYH9 is linked to pancreatic neoplasm.